monocrotaline pyrrole has been researched along with Right Ventricular Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, J; Jiang, P; Jiang, XM; Li, L; Li, M; Luo, J; Ran, H; Xie, DJ; Zhang, PY; Zhou, L | 1 |
| Aziz, A; Kanter, EM; Lee, AM; Moon, CJ; Moon, MR; Okada, S; Yamada, KA | 1 |
| Bittner, HB; Chen, EP; Davis, RD; Van Trigt, P | 2 |
4 other study(ies) available for monocrotaline pyrrole and Right Ventricular Dysfunction
| Article | Year |
|---|---|
Establishment of a canine model of pulmonary arterial hypertension induced by dehydromonocrotaline and ultrasonographic study of right ventricular remodeling.
Topics: Animals; Dimethylformamide; Dogs; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Pulmonary Arterial Hypertension; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling | 2023 |
Differential calcium handling in two canine models of right ventricular pressure overload.
Topics: Animals; Calcium; Calcium-Binding Proteins; Disease Models, Animal; Dogs; Heart Ventricles; Monocrotaline; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Dysfunction, Right; Ventricular Pressure | 2012 |
Right ventricular failure--insights provided by a new model of chronic pulmonary hypertension.
Topics: Administration, Inhalation; Animals; Blood Pressure; Cardiac Output; Dogs; Heart Rate; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Milrinone; Monocrotaline; Nitric Oxide; Pulmonary Artery; Pyridones; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right | 1997 |
Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension.
Topics: Animals; Dogs; Heart Transplantation; Hemodynamics; Hypertension, Pulmonary; Milrinone; Monocrotaline; Myocardial Contraction; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pyridones; Ventricular Dysfunction, Right; Ventricular Function, Right | 1998 |